Our goal is to reduce opioid-related harms, including overdose risk, by improving access to and education for naloxone, syringes, and buprenorphine while reducing stigma in community pharmacy settings
Community pharmacies are in an ideal position to provide direct intervention with patients and families to prevent opioid overdose.
The RESPOND TO PREVENT program provides training, resources, and tools to improve the quality and success rate of naloxone offers by community pharmacies. Through provided scripting, communication guidelines, and patient education, pharmacists and technicians can enhance patients' receptivity and decrease stigma associated with harm reduction practices.
Funding provided by the National Institute on Drug Abuse (NIDA; R01DA045745-01)
